The antitumor potential of bisphosphonates

被引：63

作者：

Clézardin, P ^{[1
]}

机构：

[1] Laennec Sch Med, INSERM, U403, F-69372 Lyon, France

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37420

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 42

页数：10

共 76 条

[1] DICHLOROMETHYLENE-DIPHOSPHONATE IN PATIENTS WITH PROSTATIC-CARCINOMA METASTATIC TO THE SKELETON [J].

ADAMI, S ;

SALVAGNO, G ;

GUARRERA, G ;

BIANCHI, G ;

DORIZZI, R ;

ROSINI, S ;

MOBILIO, G ;

LOCASCIO, V .

JOURNAL OF UROLOGY, 1985, 134 (06) :1152-1154

[2] Alendronate disturbs vesicular trafficking in osteoclasts [J].

Alakangas, A ;

Selander, K ;

Mulari, M ;

Halleen, J ;

Lehenkari, P ;

Mönkkönen, J ;

Salo, J ;

Väänänen, K .

CALCIFIED TISSUE INTERNATIONAL, 2002, 70 (01) :40-47

[3]

Alvarez Enrique, 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P316

[4] In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates [J].

Aparicio, A ;

Gardner, A ;

Tu, Y ;

Savage, A ;

Berenson, J ;

Lichtenstein, A .

LEUKEMIA, 1998, 12 (02) :220-229

[5] Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro [J].

Benford, HL ;

McGowan, NWA ;

Helfrich, MH ;

Nuttall, ME ;

Rogers, MJ .

BONE, 2001, 28 (05) :465-473

[6]

Boissier S, 2000, CANCER RES, V60, P2949

[7]

Boissier S, 1997, CANCER RES, V57, P3890

[8]

Bonjean Karine, 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P106

[9] OSTEOCLAST INHIBITION BY PAMIDRONATE IN METASTATIC PROSTATE-CANCER - A PRELIMINARY-STUDY [J].

CLARKE, NW ;

HOLBROOK, IB ;

MCCLURE, J ;

GEORGE, NJR .

BRITISH JOURNAL OF CANCER, 1991, 63 (03) :420-423

[10] Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice [J].

Clohisy, DR ;

O'Keefe, PF ;

Ramnaraine, ML .

JOURNAL OF ORTHOPAEDIC RESEARCH, 2001, 19 (04) :554-558

← 1 2 3 4 5 6 7 8 →